Cabaletta Bio (CABA) Other Non-Current Assets (2019 - 2025)
Cabaletta Bio's (CABA) quarterly Other Non-Current Assets came in at $5.2 million in Q4 2025, up 124.99% year-on-year from $2.3 million in Q4 2024, and up 43.03% quarter-over-quarter from $3.6 million in Q3 2025.
Cabaletta Bio (CABA) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Cabaletta Bio's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $5.2 million for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 124.99% year-over-year to $5.2 million in Q4 2025; TTM through Dec 2025 was $5.2 million, a 124.99% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 124.99% from the prior year.
- Other Non-Current Assets advanced to $5.2 million in Q4 2025 per CABA's latest filing, from $3.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.2 million in Q4 2025 and bottomed at $300000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $984500.0 (2022), against an average of $1.6 million.
- Across the five-year window, Other Non-Current Assets sank 41.02% in 2023 and surged 307.57% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $357000.0 in 2021, then soared by 58.26% to $565000.0 in 2022, then soared by 202.48% to $1.7 million in 2023, then surged by 34.17% to $2.3 million in 2024, then soared by 124.99% to $5.2 million in 2025.
- Per Business Quant, the three latest CABA Other Non-Current Assets figures stand at $5.2 million (Q4 2025), $3.6 million (Q3 2025), and $2.5 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.16 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 984,000.00 |
| Jun 30, 2023 | 685,000.00 |
| Mar 31, 2023 | 581,000.00 |
| Dec 31, 2022 | 565,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 965,000.00 |
| Mar 31, 2022 | 985,000.00 |
| Dec 31, 2021 | 357,000.00 |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 318,000.00 |
| Mar 31, 2021 | 300,000.00 |